|
Eribulin for breast cancer: Positive effects predominate in certain patients, negativ
Proof of minor added benefit in one patient group / Hint or indication of lesser benefit in othersEribulin (trade name: Halaven) is approved for women with locally advanced or metastatic breast...
More...
|